International Journal of Cardiovascular Research & Innovation
OPEN ACCESS
OPEN ACCESS
The COVID-19 pandemic has significantly impacted cardiovascular disease, particularly rheumatic heart disease (RHD). Importantly, RHD has been shown to be a significant risk factor for the prognosis of COVID-19, with severe valvular heart disease leading to poorer clinical outcomes of COVID-19 infection. Regardless, interest and prioritization of RHD in the world agenda remain low, even after the pandemic. Medical appointments, compliance with medical treatment, and prophylaxis should be encouraged. Prioritization of RHD research and efforts to improve diagnosis, treatment, prevention, and care are warranted.
Received 9 May 2023; Revised 31 August 2023; Accepted 14 September 2023
Address
GMA, 8th Floor, ASTEM Bldg. KRP, 134 Chudoji Minamimachi, Shimogyo-ku, KYOTO - 6008813, JAPAN
flagIcon 2530 Meridian Parkway, Suite 300, Durham, NC, 27713, USA
flagIcon 26 Kings Hill Avenue, Kings Hill, West Malling, Maidstone, ME19 4AE, MAIDSTONE, UK
